MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, ENTA has $329,503K in assets. $202,912K in debts. $37,437K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
444.20%
Quick Ratio
444.20%
Cash Ratio
83.70%
Debt to Asset Ratio
61.58%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Long-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Liability related to the sale of...
    • Others

Balance Sheets
2025-12-31
2025-09-30
2025-06-30
Income tax receivable
-0 24
Cash and cash equivalents
37,437 32,298 44,812
Short-term marketable securities
148,412 156,566 159,299
Short-term restricted cash
-0 0
Accounts receivable
8,493 6,882 8,333
Prepaid expenses and other current assets
4,342 8,590 10,240
Total current assets
198,684 204,336 222,708
Property and equipment
-59,200 -
Less accumulated depreciation and amortization
-23,805 -
Long-term marketable securities
56,055 --
Property and equipment, net
34,308 35,395 36,617
Operating lease, right-of-use assets
37,003 37,549 38,250
Long-term restricted cash
3,360 3,360 3,360
Other long-term assets
93 92 94
Total assets
329,503 280,732 301,029
Accounts payable
1,885 1,948 3,547
Accrued expenses and other current liabilities
7,575 12,751 10,853
Liability related to the sale of future royalties
31,981 30,710 27,755
Operating lease liabilities
3,287 3,146 2,394
Total current liabilities
44,728 48,555 44,549
Liability related to the sale of future royalties, net of current portion
102,822 111,132 119,943
Operating lease liabilities, net of current portion
53,782 54,757 55,656
Series 1 nonconvertible preferred stock
1,311 1,311 1,350
Other long-term liabilities
269 260 252
Total liabilities
202,912 216,015 221,750
Common stock 0.01 par value per share, 100,000 shares authorized 29,019 and 21,387 shares issued and outstanding at december 31, 2025 and september 30, 2025, respectively
290 214 214
Additional paid-in capital
543,497 469,771 465,696
Accumulated other comprehensive loss
-329 -339 -402
Accumulated deficit
-416,867 -404,929 -386,229
Total stockholders' equity
126,591 64,717 79,279
Total liabilities and stockholders' equity
329,503 280,732 301,029
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$148,412K Cash and cashequivalents$37,437K Accounts receivable$8,493K Prepaid expenses andother current assets$4,342K Total current assets$198,684K Long-term marketablesecurities$56,055K Operating lease,right-of-use assets$37,003K Property and equipment,net$34,308K Long-term restricted cash$3,360K Other long-termassets$93K Total assets$329,503K Total liabilities andstockholders' equity$329,503K Total liabilities$202,912K Total stockholders'equity$126,591K Accumulated deficit-$416,867K Accumulated othercomprehensive loss-$329K Liability related to thesale of future...$102,822K Operating leaseliabilities, net of current...$53,782K Total currentliabilities$44,728K Series 1nonconvertible preferred stock$1,311K Other long-termliabilities$269K Additional paid-in capital$543,497K Common stock 0.01 parvalue per share,...$290K Liability related to thesale of future...$31,981K Accrued expenses andother current...$7,575K Operating leaseliabilities$3,287K Accounts payable$1,885K

ENANTA PHARMACEUTICALS INC (ENTA)

ENANTA PHARMACEUTICALS INC (ENTA)